世界の心タンポナーデ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cardiac Tamponade Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3970
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、心タンポナーデの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（X線、コンピューター断層撮影（CT）、磁気共鳴画像（MRI）、冠動脈造影、心電図（EKG）、その他）、用途別市場規模（病院、診療所、心臓病センター、学術機関、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・心タンポナーデの市場動向
・企業の競争状況、市場シェア
・心タンポナーデの種類別市場規模と予測2016-2027（X線、コンピューター断層撮影（CT）、磁気共鳴画像（MRI）、冠動脈造影、心電図（EKG）、その他）
・心タンポナーデの用途別市場規模と予測2016-2027（病院、診療所、心臓病センター、学術機関、研究所、その他）
・心タンポナーデの北米市場規模2016-2027（アメリカ、カナダ）
・心タンポナーデの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・心タンポナーデのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心タンポナーデの中南米市場規模2016-2027（メキシコ、ブラジル）
・心タンポナーデの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boston Scientific Corporation、Medtronic、Abbott、Hitachi, Ltd.、Koninklijke Philips N.V.、Siemens AG、Cardio Vascular Services、General Electric、Edwards Lifesciences Corporation、Summit Medical Group、Clinical Care Options, LLC.、High Impact Incorporated、Epic Medical Concepts & Innovations）
・結論

Cardiac tamponade, also known as pericardial tamponade, is when fluid in the pericardium (the sac around the heart) builds up, resulting in compression of the heart. Onset may be rapid or gradual. Symptoms typically include those of cardiogenic shock including shortness of breath, weakness, lightheadedness, and cough.

Market Analysis and Insights: Global Cardiac Tamponade Market
The global Cardiac Tamponade market size is projected to reach US$ 5231.8 million by 2027, from US$ 4094 million in 2020, at a CAGR of 3.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiac Tamponade market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiac Tamponade market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiac Tamponade market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiac Tamponade market.

Global Cardiac Tamponade Scope and Market Size
Cardiac Tamponade market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Tamponade market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
X-Ray
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Coronary Angiography
Electrocardiogram (EKG)
Others.

Segment by Application
Hospitals
Clinics
Cardiac Centers
Academic Institutes
Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific Corporation
Medtronic
Abbott
Hitachi, Ltd.
Koninklijke Philips N.V.
Siemens AG
Cardio Vascular Services
General Electric
Edwards Lifesciences Corporation
Summit Medical Group
Clinical Care Options, LLC.
High Impact Incorporated
Epic Medical Concepts & Innovations

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Tamponade Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 X-Ray
1.2.3 Computed Tomography (CT)
1.2.4 Magnetic Resonance Imaging (MRI)
1.2.5 Coronary Angiography
1.2.6 Electrocardiogram (EKG)
1.2.7 Others.
1.3 Market by Application
1.3.1 Global Cardiac Tamponade Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cardiac Centers
1.3.5 Academic Institutes
1.3.6 Research Institutes
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cardiac Tamponade Market Perspective (2016-2027)
2.2 Cardiac Tamponade Growth Trends by Regions
2.2.1 Cardiac Tamponade Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiac Tamponade Historic Market Share by Regions (2016-2021)
2.2.3 Cardiac Tamponade Forecasted Market Size by Regions (2022-2027)
2.3 Cardiac Tamponade Industry Dynamic
2.3.1 Cardiac Tamponade Market Trends
2.3.2 Cardiac Tamponade Market Drivers
2.3.3 Cardiac Tamponade Market Challenges
2.3.4 Cardiac Tamponade Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cardiac Tamponade Players by Revenue
3.1.1 Global Top Cardiac Tamponade Players by Revenue (2016-2021)
3.1.2 Global Cardiac Tamponade Revenue Market Share by Players (2016-2021)
3.2 Global Cardiac Tamponade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiac Tamponade Revenue
3.4 Global Cardiac Tamponade Market Concentration Ratio
3.4.1 Global Cardiac Tamponade Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Tamponade Revenue in 2020
3.5 Cardiac Tamponade Key Players Head office and Area Served
3.6 Key Players Cardiac Tamponade Product Solution and Service
3.7 Date of Enter into Cardiac Tamponade Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiac Tamponade Breakdown Data by Type
4.1 Global Cardiac Tamponade Historic Market Size by Type (2016-2021)
4.2 Global Cardiac Tamponade Forecasted Market Size by Type (2022-2027)

5 Cardiac Tamponade Breakdown Data by Application
5.1 Global Cardiac Tamponade Historic Market Size by Application (2016-2021)
5.2 Global Cardiac Tamponade Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cardiac Tamponade Market Size (2016-2027)
6.2 North America Cardiac Tamponade Market Size by Type
6.2.1 North America Cardiac Tamponade Market Size by Type (2016-2021)
6.2.2 North America Cardiac Tamponade Market Size by Type (2022-2027)
6.2.3 North America Cardiac Tamponade Market Size by Type (2016-2027)
6.3 North America Cardiac Tamponade Market Size by Application
6.3.1 North America Cardiac Tamponade Market Size by Application (2016-2021)
6.3.2 North America Cardiac Tamponade Market Size by Application (2022-2027)
6.3.3 North America Cardiac Tamponade Market Size by Application (2016-2027)
6.4 North America Cardiac Tamponade Market Size by Country
6.4.1 North America Cardiac Tamponade Market Size by Country (2016-2021)
6.4.2 North America Cardiac Tamponade Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cardiac Tamponade Market Size (2016-2027)
7.2 Europe Cardiac Tamponade Market Size by Type
7.2.1 Europe Cardiac Tamponade Market Size by Type (2016-2021)
7.2.2 Europe Cardiac Tamponade Market Size by Type (2022-2027)
7.2.3 Europe Cardiac Tamponade Market Size by Type (2016-2027)
7.3 Europe Cardiac Tamponade Market Size by Application
7.3.1 Europe Cardiac Tamponade Market Size by Application (2016-2021)
7.3.2 Europe Cardiac Tamponade Market Size by Application (2022-2027)
7.3.3 Europe Cardiac Tamponade Market Size by Application (2016-2027)
7.4 Europe Cardiac Tamponade Market Size by Country
7.4.1 Europe Cardiac Tamponade Market Size by Country (2016-2021)
7.4.2 Europe Cardiac Tamponade Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cardiac Tamponade Market Size (2016-2027)
8.2 Asia-Pacific Cardiac Tamponade Market Size by Type
8.2.1 Asia-Pacific Cardiac Tamponade Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiac Tamponade Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiac Tamponade Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiac Tamponade Market Size by Application
8.3.1 Asia-Pacific Cardiac Tamponade Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiac Tamponade Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiac Tamponade Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiac Tamponade Market Size by Region
8.4.1 Asia-Pacific Cardiac Tamponade Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiac Tamponade Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cardiac Tamponade Market Size (2016-2027)
9.2 Latin America Cardiac Tamponade Market Size by Type
9.2.1 Latin America Cardiac Tamponade Market Size by Type (2016-2021)
9.2.2 Latin America Cardiac Tamponade Market Size by Type (2022-2027)
9.2.3 Latin America Cardiac Tamponade Market Size by Type (2016-2027)
9.3 Latin America Cardiac Tamponade Market Size by Application
9.3.1 Latin America Cardiac Tamponade Market Size by Application (2016-2021)
9.3.2 Latin America Cardiac Tamponade Market Size by Application (2022-2027)
9.3.3 Latin America Cardiac Tamponade Market Size by Application (2016-2027)
9.4 Latin America Cardiac Tamponade Market Size by Country
9.4.1 Latin America Cardiac Tamponade Market Size by Country (2016-2021)
9.4.2 Latin America Cardiac Tamponade Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cardiac Tamponade Market Size (2016-2027)
10.2 Middle East & Africa Cardiac Tamponade Market Size by Type
10.2.1 Middle East & Africa Cardiac Tamponade Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiac Tamponade Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiac Tamponade Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiac Tamponade Market Size by Application
10.3.1 Middle East & Africa Cardiac Tamponade Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiac Tamponade Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiac Tamponade Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiac Tamponade Market Size by Country
10.4.1 Middle East & Africa Cardiac Tamponade Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiac Tamponade Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Details
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Cardiac Tamponade Introduction
11.1.4 Boston Scientific Corporation Revenue in Cardiac Tamponade Business (2016-2021)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Cardiac Tamponade Introduction
11.2.4 Medtronic Revenue in Cardiac Tamponade Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Cardiac Tamponade Introduction
11.3.4 Abbott Revenue in Cardiac Tamponade Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Details
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Cardiac Tamponade Introduction
11.4.4 Hitachi, Ltd. Revenue in Cardiac Tamponade Business (2016-2021)
11.4.5 Hitachi, Ltd. Recent Development
11.5 Koninklijke Philips N.V.
11.5.1 Koninklijke Philips N.V. Company Details
11.5.2 Koninklijke Philips N.V. Business Overview
11.5.3 Koninklijke Philips N.V. Cardiac Tamponade Introduction
11.5.4 Koninklijke Philips N.V. Revenue in Cardiac Tamponade Business (2016-2021)
11.5.5 Koninklijke Philips N.V. Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Details
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Cardiac Tamponade Introduction
11.6.4 Siemens AG Revenue in Cardiac Tamponade Business (2016-2021)
11.6.5 Siemens AG Recent Development
11.7 Cardio Vascular Services
11.7.1 Cardio Vascular Services Company Details
11.7.2 Cardio Vascular Services Business Overview
11.7.3 Cardio Vascular Services Cardiac Tamponade Introduction
11.7.4 Cardio Vascular Services Revenue in Cardiac Tamponade Business (2016-2021)
11.7.5 Cardio Vascular Services Recent Development
11.8 General Electric
11.8.1 General Electric Company Details
11.8.2 General Electric Business Overview
11.8.3 General Electric Cardiac Tamponade Introduction
11.8.4 General Electric Revenue in Cardiac Tamponade Business (2016-2021)
11.8.5 General Electric Recent Development
11.9 Edwards Lifesciences Corporation
11.9.1 Edwards Lifesciences Corporation Company Details
11.9.2 Edwards Lifesciences Corporation Business Overview
11.9.3 Edwards Lifesciences Corporation Cardiac Tamponade Introduction
11.9.4 Edwards Lifesciences Corporation Revenue in Cardiac Tamponade Business (2016-2021)
11.9.5 Edwards Lifesciences Corporation Recent Development
11.10 Summit Medical Group
11.10.1 Summit Medical Group Company Details
11.10.2 Summit Medical Group Business Overview
11.10.3 Summit Medical Group Cardiac Tamponade Introduction
11.10.4 Summit Medical Group Revenue in Cardiac Tamponade Business (2016-2021)
11.10.5 Summit Medical Group Recent Development
11.11 Clinical Care Options, LLC.
11.11.1 Clinical Care Options, LLC. Company Details
11.11.2 Clinical Care Options, LLC. Business Overview
11.11.3 Clinical Care Options, LLC. Cardiac Tamponade Introduction
11.11.4 Clinical Care Options, LLC. Revenue in Cardiac Tamponade Business (2016-2021)
11.11.5 Clinical Care Options, LLC. Recent Development
11.12 High Impact Incorporated
11.12.1 High Impact Incorporated Company Details
11.12.2 High Impact Incorporated Business Overview
11.12.3 High Impact Incorporated Cardiac Tamponade Introduction
11.12.4 High Impact Incorporated Revenue in Cardiac Tamponade Business (2016-2021)
11.12.5 High Impact Incorporated Recent Development
11.13 Epic Medical Concepts & Innovations
11.13.1 Epic Medical Concepts & Innovations Company Details
11.13.2 Epic Medical Concepts & Innovations Business Overview
11.13.3 Epic Medical Concepts & Innovations Cardiac Tamponade Introduction
11.13.4 Epic Medical Concepts & Innovations Revenue in Cardiac Tamponade Business (2016-2021)
11.13.5 Epic Medical Concepts & Innovations Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cardiac Tamponade Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of X-Ray
Table 3. Key Players of Computed Tomography (CT)
Table 4. Key Players of Magnetic Resonance Imaging (MRI)
Table 5. Key Players of Coronary Angiography
Table 6. Key Players of Electrocardiogram (EKG)
Table 7. Key Players of Others.
Table 8. Global Cardiac Tamponade Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cardiac Tamponade Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cardiac Tamponade Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cardiac Tamponade Market Share by Regions (2016-2021)
Table 12. Global Cardiac Tamponade Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cardiac Tamponade Market Share by Regions (2022-2027)
Table 14. Cardiac Tamponade Market Trends
Table 15. Cardiac Tamponade Market Drivers
Table 16. Cardiac Tamponade Market Challenges
Table 17. Cardiac Tamponade Market Restraints
Table 18. Global Cardiac Tamponade Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cardiac Tamponade Market Share by Players (2016-2021)
Table 20. Global Top Cardiac Tamponade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Tamponade as of 2020)
Table 21. Ranking of Global Top Cardiac Tamponade Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cardiac Tamponade Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cardiac Tamponade Product Solution and Service
Table 25. Date of Enter into Cardiac Tamponade Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cardiac Tamponade Revenue Market Share by Type (2016-2021)
Table 29. Global Cardiac Tamponade Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cardiac Tamponade Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cardiac Tamponade Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cardiac Tamponade Revenue Market Share by Application (2016-2021)
Table 33. Global Cardiac Tamponade Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cardiac Tamponade Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cardiac Tamponade Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cardiac Tamponade Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cardiac Tamponade Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cardiac Tamponade Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cardiac Tamponade Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cardiac Tamponade Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cardiac Tamponade Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cardiac Tamponade Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cardiac Tamponade Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cardiac Tamponade Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cardiac Tamponade Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cardiac Tamponade Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cardiac Tamponade Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cardiac Tamponade Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cardiac Tamponade Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cardiac Tamponade Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cardiac Tamponade Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cardiac Tamponade Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cardiac Tamponade Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cardiac Tamponade Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cardiac Tamponade Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cardiac Tamponade Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cardiac Tamponade Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cardiac Tamponade Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cardiac Tamponade Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cardiac Tamponade Market Size by Country (2022-2027) & (US$ Million)
Table 65. Boston Scientific Corporation Company Details
Table 66. Boston Scientific Corporation Business Overview
Table 67. Boston Scientific Corporation Cardiac Tamponade Product
Table 68. Boston Scientific Corporation Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 69. Boston Scientific Corporation Recent Development
Table 70. Medtronic Company Details
Table 71. Medtronic Business Overview
Table 72. Medtronic Cardiac Tamponade Product
Table 73. Medtronic Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 74. Medtronic Recent Development
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Cardiac Tamponade Product
Table 78. Abbott Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. Hitachi, Ltd. Company Details
Table 81. Hitachi, Ltd. Business Overview
Table 82. Hitachi, Ltd. Cardiac Tamponade Product
Table 83. Hitachi, Ltd. Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 84. Hitachi, Ltd. Recent Development
Table 85. Koninklijke Philips N.V. Company Details
Table 86. Koninklijke Philips N.V. Business Overview
Table 87. Koninklijke Philips N.V. Cardiac Tamponade Product
Table 88. Koninklijke Philips N.V. Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 89. Koninklijke Philips N.V. Recent Development
Table 90. Siemens AG Company Details
Table 91. Siemens AG Business Overview
Table 92. Siemens AG Cardiac Tamponade Product
Table 93. Siemens AG Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 94. Siemens AG Recent Development
Table 95. Cardio Vascular Services Company Details
Table 96. Cardio Vascular Services Business Overview
Table 97. Cardio Vascular Services Cardiac Tamponade Product
Table 98. Cardio Vascular Services Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 99. Cardio Vascular Services Recent Development
Table 100. General Electric Company Details
Table 101. General Electric Business Overview
Table 102. General Electric Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 103. General Electric Recent Development
Table 104. Edwards Lifesciences Corporation Company Details
Table 105. Edwards Lifesciences Corporation Business Overview
Table 106. Edwards Lifesciences Corporation Cardiac Tamponade Product
Table 107. Edwards Lifesciences Corporation Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 108. Edwards Lifesciences Corporation Recent Development
Table 109. Summit Medical Group Company Details
Table 110. Summit Medical Group Business Overview
Table 111. Summit Medical Group Cardiac Tamponade Product
Table 112. Summit Medical Group Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 113. Summit Medical Group Recent Development
Table 114. Clinical Care Options, LLC. Company Details
Table 115. Clinical Care Options, LLC. Business Overview
Table 116. Clinical Care Options, LLC. Cardiac Tamponade Product
Table 117. Clinical Care Options, LLC. Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 118. Clinical Care Options, LLC. Recent Development
Table 119. High Impact Incorporated Company Details
Table 120. High Impact Incorporated Business Overview
Table 121. High Impact Incorporated Cardiac Tamponade Product
Table 122. High Impact Incorporated Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 123. High Impact Incorporated Recent Development
Table 124. Epic Medical Concepts & Innovations Company Details
Table 125. Epic Medical Concepts & Innovations Business Overview
Table 126. Epic Medical Concepts & Innovations Cardiac Tamponade Product
Table 127. Epic Medical Concepts & Innovations Revenue in Cardiac Tamponade Business (2016-2021) & (US$ Million)
Table 128. Epic Medical Concepts & Innovations Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Tamponade Market Share by Type: 2020 VS 2027
Figure 2. X-Ray Features
Figure 3. Computed Tomography (CT) Features
Figure 4. Magnetic Resonance Imaging (MRI) Features
Figure 5. Coronary Angiography Features
Figure 6. Electrocardiogram (EKG) Features
Figure 7. Others. Features
Figure 8. Global Cardiac Tamponade Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Cardiac Centers Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Cardiac Tamponade Report Years Considered
Figure 16. Global Cardiac Tamponade Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cardiac Tamponade Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cardiac Tamponade Market Share by Regions: 2020 VS 2027
Figure 19. Global Cardiac Tamponade Market Share by Regions (2022-2027)
Figure 20. Global Cardiac Tamponade Market Share by Players in 2020
Figure 21. Global Top Cardiac Tamponade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Tamponade as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cardiac Tamponade Revenue in 2020
Figure 23. Global Cardiac Tamponade Revenue Market Share by Type (2016-2021)
Figure 24. Global Cardiac Tamponade Revenue Market Share by Type (2022-2027)
Figure 25. North America Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cardiac Tamponade Market Share by Type (2016-2027)
Figure 27. North America Cardiac Tamponade Market Share by Application (2016-2027)
Figure 28. North America Cardiac Tamponade Market Share by Country (2016-2027)
Figure 29. United States Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cardiac Tamponade Market Share by Type (2016-2027)
Figure 33. Europe Cardiac Tamponade Market Share by Application (2016-2027)
Figure 34. Europe Cardiac Tamponade Market Share by Country (2016-2027)
Figure 35. Germany Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cardiac Tamponade Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cardiac Tamponade Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cardiac Tamponade Market Share by Region (2016-2027)
Figure 45. China Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cardiac Tamponade Market Share by Type (2016-2027)
Figure 53. Latin America Cardiac Tamponade Market Share by Application (2016-2027)
Figure 54. Latin America Cardiac Tamponade Market Share by Country (2016-2027)
Figure 55. Mexico Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cardiac Tamponade Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cardiac Tamponade Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cardiac Tamponade Market Share by Country (2016-2027)
Figure 61. Turkey Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cardiac Tamponade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Boston Scientific Corporation Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 65. Medtronic Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 67. Hitachi, Ltd. Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 68. Koninklijke Philips N.V. Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 69. Siemens AG Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 70. Cardio Vascular Services Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 71. General Electric Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 72. Edwards Lifesciences Corporation Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 73. Summit Medical Group Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 74. Clinical Care Options, LLC. Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 75. High Impact Incorporated Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 76. Epic Medical Concepts & Innovations Revenue Growth Rate in Cardiac Tamponade Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

以下、関連資料のご紹介

世界の心臓リーダーシステム市場規模・現状・予測（2021年-2027年）

Global Cardiac Reader System Market Size, Status and Forecast 2021-2027
QFJ1-5647 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、心臓リーダーシステムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロポニン、クレアチンキナーゼ、その他）、用途別市場規模（病院＆診療所、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の心臓バイオマーカー検査市場規模・現状・予測（2021年-2027年）

Global Cardiac Biomarkers Testing Market Size, Status and Forecast 2021-2027
QFJ1-5117 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、心臓バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心筋クレアチンキナーゼ（CK-MB）、トロポニン（T＆I）、ミオグロビン、脳性ナトリウム利尿ペプチド（BNP）/NT-proBNP...

世界の心臓外科装置市場規模・現状・予測（2021年-2027年）

Global Cardiac Surgical Devices Market Size, Status and Forecast 2021-2027
QFJ1-5120 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、心臓外科装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心拍動下手術システム、心肺バイパス装置、心臓アブレーション装置、輸液用ディスポーザブル）、用途別市場規模（先天性心疾患、心不整脈、冠状動脈性...

世界の経カテーテル肺動脈弁置換市場規模・現状・予測（2021年-2027年）

Global Transcatheter Pulmonary Valve Replacement Market Size, Status and Forecast 2021-2027
QFJ1-5367 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、経カテーテル肺動脈弁置換の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルーン拡張、自己拡張）、用途別市場規模（病院、外科医院、心臓カテーテル検査室）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のプレリキサフォル市場規模・現状・予測（2021年-2027年）

Global Plerixafor Market Size, Status and Forecast 2021-2027
QFJ1-5955 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、プレリキサフォルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（24MG / 1.2ML、タイプII）、用途別市場規模（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別市場規模...

世界のバレニクリン市場規模・現状・予測（2021年-2027年）

Global Varenicline Market Size, Status and Forecast 2021-2027
QFJ1-6060 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、バレニクリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（0.5mg錠、1mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027
QFJ1-6028 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（...

世界の心不全治療薬市場規模・現状・予測（2021年-2027年）

Global Heart Failure Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5770 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、心不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、予後、治療オプション＆治療アルゴリズム）、用途別市場規模（病院、診療所、医学研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のリンコマイシン市場規模・現状・予測（2021年-2027年）

Global Lincomycin Market Size, Status and Forecast 2021-2027
QFJ1-4427 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リンコマイシンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（高純度タイプ、一般タイプ）、用途別市場規模（動物用医薬品、動物飼料添加物）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の心臓リーダーシステム市場規模・現状・予測（2021年-2027年） Cardiac Reader System provide high throughput point-of-care solutions for the diagnosis of myocardial infarction and other cardiac-related diseases by measuring levels of STAT, cardiac troponin, CKM and CKB, myoglobin and/or D-dimer in approximately as low as 14 minutes; equivalent to 36 tests per h…
世界の心臓バイオマーカー検査市場規模・現状・予測（2021年-2027年） Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and car…
世界の心臓外科装置市場規模・現状・予測（2021年-2027年） There is a high prevalence of cardiac diseases worldwide, hence an increase in the number of cardiac surgeries. Products such as beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable are used for cardiac surgery. The key factors that driv…
世界の超音波画像ソリューション市場規模・現状・予測（2021年-2027年） Ultrasound Imaging is an essential diagnostic tool that utilizes high frequency sound waves to generate visual images of internal organs, blood flow or tissues inside the human body. The high frequency sound waves emitted out of an ultrasound device are transmitted to the affected area under examina…
世界の心臓内イメージング市場規模・現状・予測（2021年-2027年） There has been a significant process in the file of coronary imaging in the past decade. The non-fluoroscopic intracardiac imaging is increasingly used to guide interventional electrophysiology therapeutic procedures. This is primarily due to the advantage of real-time, direct observation and improv…